Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B

BACKGROUND: Visceral leishmaniasis (VL), a potentially fatal disease, is most prevalent in the Indian subcontinent, East Africa and South America. Since the conventional antileishmanial drugs have many limitations we evaluated a new ergosterol rich liposomal amphotericin B formulation, KALSOME™10 fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Asad, Mohammad, Bhattacharya, Pradyot, Banerjee, Antara, Ali, Nahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411769/
https://www.ncbi.nlm.nih.gov/pubmed/25884796
http://dx.doi.org/10.1186/s12879-015-0928-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411769/
https://www.ncbi.nlm.nih.gov/pubmed/25884796
http://dx.doi.org/10.1186/s12879-015-0928-6

Ejemplares similares